Double Blind Controlled Trial of an Extensively Hydrolyzed Formula With a Probiotic vs. an Extensively Hydrolyzed Formula Without a Probiotic
Not Applicable
Completed
- Conditions
- Allergy
- Interventions
- Other: Extensively Hydrolyzed Formula with a ProbioticOther: Extensively Hydrolyzed Formula without a Probiotic
- Registration Number
- NCT01181297
- Lead Sponsor
- Mead Johnson Nutrition
- Brief Summary
The purpose of this study is to confirm the hypoallergenicity of an extensively hydrolyzed formula with an added probiotic in children with documented milk allergy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
- ≤14 years of age
- Essentially asymptomatic for a minimum of 7 days pre-challenge.
- Successful previous consumption of Extensively Hydrolyzed Formula within 1 week of study enrollment
- Medically documented allergy to cow's milk
Exclusion Criteria
- Presence of underlying systemic disease or other illness
- Used Beta-blockers within 12-24 hours of challenges
- Use of short-acting antihistamines within 3 days
- Use of medium-acting antihistamines within 7 days
- Use of long-acting antihistamines within 6 weeks
- Use of oral steroid medication within 3 weeks
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Extensively Hydrolyzed Formula with a Probiotic Extensively Hydrolyzed Formula with a Probiotic Extensively Hydrolyzed Formula with a Probiotic Extensively Hydrolyzed Formula without a Probiotic Extensively Hydrolyzed Formula without a Probiotic -
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Dept. of Paediatrics, Azienda Ospedaliera di Padova
🇮🇹Padova, Veneto, Italy
Wilhelmina Children's Hospital
🇳🇱Utrecht, Netherlands